Corcept Therapeutics CORT Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corcept Therapeutics's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corcept Therapeutics's total assets?
- Corcept Therapeutics (CORT) reported total assets of $814.88M in Q1 2026.
- How has Corcept Therapeutics's total assets changed year-over-year?
- Corcept Therapeutics's total assets decreased by 3.7% year-over-year, from $846.46M to $814.88M.
- What is the long-term trend for Corcept Therapeutics's total assets?
- Over 5 years (2020 to 2025), Corcept Therapeutics's total assets has grown at a 7.9% compound annual growth rate (CAGR), from $571.73M to $836.65M.
- What does total assets mean?
- The total value of everything the company owns, including cash, equipment, and other resources.
- How do you interpret total assets?
- Growth in total assets generally signals company expansion, though it should be evaluated alongside liabilities to determine net worth.
- How does total assets compare across companies?
- A fundamental metric for comparing the overall scale and resource base of peer companies.